TR199900770T2 - Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�. - Google Patents

Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.

Info

Publication number
TR199900770T2
TR199900770T2 TR1999/00770T TR9900770T TR199900770T2 TR 199900770 T2 TR199900770 T2 TR 199900770T2 TR 1999/00770 T TR1999/00770 T TR 1999/00770T TR 9900770 T TR9900770 T TR 9900770T TR 199900770 T2 TR199900770 T2 TR 199900770T2
Authority
TR
Turkey
Prior art keywords
treatment
atpase
nasal polyps
present
widal
Prior art date
Application number
TR1999/00770T
Other languages
English (en)
Turkish (tr)
Inventor
Lindberg Per
Pinas-Masso Joan
Serra-Carreras Jordi
Trofast Jan
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of TR199900770T2 publication Critical patent/TR199900770T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
TR1999/00770T 1996-10-11 1997-10-01 Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�. TR199900770T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment

Publications (1)

Publication Number Publication Date
TR199900770T2 true TR199900770T2 (xx) 1999-06-21

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00770T TR199900770T2 (xx) 1996-10-11 1997-10-01 Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.

Country Status (33)

Country Link
EP (1) EP0946175B1 (enrdf_load_stackoverflow)
JP (1) JP4100713B2 (enrdf_load_stackoverflow)
KR (1) KR100510812B1 (enrdf_load_stackoverflow)
CN (1) CN1146416C (enrdf_load_stackoverflow)
AR (1) AR008886A1 (enrdf_load_stackoverflow)
AT (1) ATE230597T1 (enrdf_load_stackoverflow)
AU (1) AU738310B2 (enrdf_load_stackoverflow)
BR (1) BR9711896A (enrdf_load_stackoverflow)
CA (1) CA2268305C (enrdf_load_stackoverflow)
CZ (1) CZ298799B6 (enrdf_load_stackoverflow)
DE (1) DE69718347T2 (enrdf_load_stackoverflow)
DK (1) DK0946175T3 (enrdf_load_stackoverflow)
EE (1) EE04043B1 (enrdf_load_stackoverflow)
ES (1) ES2188995T3 (enrdf_load_stackoverflow)
HU (1) HUP0000036A3 (enrdf_load_stackoverflow)
ID (1) ID23692A (enrdf_load_stackoverflow)
IL (1) IL129324A0 (enrdf_load_stackoverflow)
IS (1) IS1930B (enrdf_load_stackoverflow)
MY (1) MY117918A (enrdf_load_stackoverflow)
NO (1) NO321007B1 (enrdf_load_stackoverflow)
NZ (1) NZ334786A (enrdf_load_stackoverflow)
PL (1) PL190902B1 (enrdf_load_stackoverflow)
PT (1) PT946175E (enrdf_load_stackoverflow)
RS (1) RS49599B (enrdf_load_stackoverflow)
RU (1) RU2197966C2 (enrdf_load_stackoverflow)
SA (1) SA97180641B1 (enrdf_load_stackoverflow)
SE (1) SE9603725D0 (enrdf_load_stackoverflow)
SK (1) SK284252B6 (enrdf_load_stackoverflow)
TR (1) TR199900770T2 (enrdf_load_stackoverflow)
TW (1) TW568784B (enrdf_load_stackoverflow)
UA (1) UA59374C2 (enrdf_load_stackoverflow)
WO (1) WO1998016228A1 (enrdf_load_stackoverflow)
ZA (1) ZA978842B (enrdf_load_stackoverflow)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
ATE399541T1 (de) 1998-08-18 2008-07-15 Univ California Epidermale wachstumsfaktor rezeptor antagonisten zur behandlung stark vermehrter schleimsekretion in der lunge
ATE487506T1 (de) * 1999-03-03 2010-11-15 Optinose As Nasales verabreichungsgerät
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
EP1487447A1 (en) * 2002-03-14 2004-12-22 ALTANA Pharma AG Use of proton pump inhibitors for the treatment of airway disorders
RS95304A (en) * 2002-05-07 2006-12-15 Altana Pharma Ag. New combination fortreating airway disorders
RS95204A (en) * 2002-05-07 2006-12-15 Altana Pharma Ag. Combination for the treatment of airway disorders
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
RS51707B (sr) 2002-12-12 2011-10-31 Nycomed Gmbh. Kombinacija leka sastavljena od r, r - formoterola i ciklezonida
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8371292B2 (en) 2003-09-16 2013-02-12 Nycomed Gmbh Use of ciclesonide for the treatment of respiratory diseases
RU2252025C1 (ru) * 2003-11-28 2005-05-20 Дальневосточный государственный медицинский университет Способ лечения избыточной грануляционной ткани гортани и трахеи
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
YU16399A (sh) 2000-03-21
NO991619D0 (no) 1999-04-06
AU4640997A (en) 1998-05-11
BR9711896A (pt) 1999-08-24
KR20000049046A (ko) 2000-07-25
HUP0000036A2 (hu) 2002-05-29
AU738310B2 (en) 2001-09-13
MY117918A (en) 2004-08-30
SK38499A3 (en) 2000-03-13
EP0946175A1 (en) 1999-10-06
ATE230597T1 (de) 2003-01-15
RU2197966C2 (ru) 2003-02-10
PL190902B1 (pl) 2006-02-28
ZA978842B (en) 1998-04-14
UA59374C2 (uk) 2003-09-15
SK284252B6 (sk) 2004-12-01
NO321007B1 (no) 2006-02-27
WO1998016228A1 (en) 1998-04-23
IS1930B (is) 2004-05-18
CZ298799B6 (cs) 2008-02-06
KR100510812B1 (ko) 2005-08-31
PL332692A1 (en) 1999-09-27
HUP0000036A3 (en) 2003-02-28
NZ334786A (en) 2000-12-22
CZ122999A3 (cs) 1999-09-15
JP2001508034A (ja) 2001-06-19
IS5021A (is) 1999-04-08
PT946175E (pt) 2003-04-30
RS49599B (sr) 2007-06-04
ID23692A (id) 2000-05-11
NO991619L (no) 1999-04-06
DK0946175T3 (da) 2003-03-17
DE69718347D1 (de) 2003-02-13
TW568784B (en) 2004-01-01
SA97180641B1 (ar) 2005-12-18
HK1022848A1 (en) 2000-08-25
ES2188995T3 (es) 2003-07-01
HU0000036D0 (enrdf_load_stackoverflow) 2002-05-29
CN1146416C (zh) 2004-04-21
IL129324A0 (en) 2000-02-17
CN1232397A (zh) 1999-10-20
EP0946175B1 (en) 2003-01-08
DE69718347T2 (de) 2003-08-28
EE9900118A (et) 1999-10-15
AR008886A1 (es) 2000-02-23
SE9603725D0 (sv) 1996-10-11
CA2268305C (en) 2006-11-28
CA2268305A1 (en) 1998-04-23
EE04043B1 (et) 2003-06-16
JP4100713B2 (ja) 2008-06-11

Similar Documents

Publication Publication Date Title
TR199900770T2 (xx) Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.
EP1028715A4 (en) FORMULATION FOR NASAL SUPPORT AND METHOD OF USE THEREOF
BG101118A (en) Therapeutical compounds
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE332918T1 (de) Neoglycoproteine
ATE235893T1 (de) Orale zubereitung enthaltend zonula occludens toxin und einen biologisch aktiven wirkstoff sowie deren verwendung
ID28003A (id) Turunan-turunan adamantana
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
TR199802423T2 (xx) Konsantre antikor terkibi.
PT1137430E (pt) Terapeutica para a supressao dos ruidos do ressonar
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
SE9402880D0 (sv) New peptide derivatives
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
TR199901385T2 (xx) Piperidin t�revleri.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
MX9604305A (es) Novedosos carbamatos y ureas como modificadores a la resistencia a multiples drogas.
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.